-
Article
Open AccessLow skeletal muscle mass predicts frailty in elderly head and neck cancer patients
Treatment of head and neck cancer (HNC) carries a high risk of adverse outcomes in patients, especially in frail elderly. Therefore, it is important to identify patients in which treatment benefits outweigh th...
-
Article
Open AccessThe predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy
This study aims to investigate the predictive value of low skeletal muscle mass (SMM) for cetuximab dose-limiting toxicity (DLT) and its prognostic value in head and neck squamous cell carcinoma (HNSCC) patien...
-
Article
Reply to comment on “Sarcopenia is a prognostic factor for overall survival in elderly patients with head and neck cancer”
-
Article
Open AccessSarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer
Sarcopenia is known as a geriatric syndrome associated with increased disability and decreased survival in elderly patients. In oncological patients, pretreatment low skeletal muscle mass (SMM), sometimes refe...
